Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)
China
· Delayed Price · Currency is CNY 5.23
+0.22 (4.39%)
Jun 6, 2025, 2:45 PM CST
SHA:603669 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 256.88 | 254.09 | 343.42 | 575.76 | 986.94 | 1,567 | Upgrade
|
| Trading Asset Securities | 13.75 | 31.22 | 390.59 | 389.51 | 579.13 | 180 | Upgrade
|
| Cash & Short-Term Investments | 270.63 | 285.31 | 734.01 | 965.28 | 1,566 | 1,747 | Upgrade
|
| Cash Growth | -54.95% | -61.13% | -23.96% | -38.36% | -10.36% | 101.55% | Upgrade
|
| Accounts Receivable | 264.55 | 243.2 | 65.6 | 92.21 | 124.89 | 172.17 | Upgrade
|
| Other Receivables | 4.89 | 4.69 | 2.18 | 3.53 | 7.71 | 9.73 | Upgrade
|
| Receivables | 269.44 | 247.89 | 67.78 | 95.74 | 132.61 | 181.9 | Upgrade
|
| Inventory | 23.3 | 27.88 | 56.77 | 49.14 | 51.67 | 69.06 | Upgrade
|
| Other Current Assets | 11.29 | 25.53 | 22.97 | 21.89 | 37.95 | 40.87 | Upgrade
|
| Total Current Assets | 574.66 | 586.61 | 881.53 | 1,132 | 1,788 | 2,039 | Upgrade
|
| Property, Plant & Equipment | 463.77 | 469.67 | 505.35 | 496.32 | 484.53 | 465.47 | Upgrade
|
| Long-Term Investments | 72.32 | 75.67 | 100.87 | 77.8 | 66.67 | 63.05 | Upgrade
|
| Goodwill | - | - | - | - | 2.03 | 2.03 | Upgrade
|
| Other Intangible Assets | 99.18 | 100.9 | 108.44 | 115.79 | 124.1 | 102.7 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | 2.2 | 0.21 | 6.83 | 4.12 | Upgrade
|
| Long-Term Deferred Charges | 13.68 | 14.23 | 17.15 | 20.1 | 23.92 | 26.5 | Upgrade
|
| Other Long-Term Assets | 7.82 | 8.25 | 9.02 | 13.22 | 18 | 13.52 | Upgrade
|
| Total Assets | 1,231 | 1,255 | 1,625 | 1,855 | 2,514 | 2,716 | Upgrade
|
| Accounts Payable | 116.25 | 89.13 | 85.5 | 49.26 | 48.53 | 39.02 | Upgrade
|
| Accrued Expenses | 2.72 | 23.37 | 13.29 | 14.6 | 25.25 | 65.4 | Upgrade
|
| Short-Term Debt | - | - | 117.41 | 205.24 | 460.29 | 389.75 | Upgrade
|
| Current Portion of Long-Term Debt | - | 0.42 | 0.38 | - | 85.06 | - | Upgrade
|
| Current Portion of Leases | - | 1.77 | 2.64 | 1.14 | 3.19 | - | Upgrade
|
| Current Income Taxes Payable | 3.74 | 0.03 | 0.31 | 0.02 | 1.28 | 11.58 | Upgrade
|
| Current Unearned Revenue | 9.69 | 6.88 | 10.48 | 8.84 | 6.61 | 11.18 | Upgrade
|
| Other Current Liabilities | 76.82 | 97.72 | 13.1 | 23.33 | 18.64 | 214.65 | Upgrade
|
| Total Current Liabilities | 209.21 | 219.31 | 243.11 | 302.42 | 648.85 | 731.57 | Upgrade
|
| Long-Term Debt | 262.99 | 257.99 | 439.34 | 412.52 | 385.91 | 497.54 | Upgrade
|
| Long-Term Leases | 4.07 | 4.07 | 5.84 | 1.07 | 14.77 | - | Upgrade
|
| Long-Term Unearned Revenue | 2.34 | 2.41 | 2.8 | 4.09 | 5.81 | 7.22 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 1.67 | 1.78 | 2.42 | 0.74 | 0.19 | - | Upgrade
|
| Total Liabilities | 480.29 | 485.57 | 693.52 | 720.84 | 1,056 | 1,236 | Upgrade
|
| Common Stock | 721.24 | 721.24 | 721.24 | 721.24 | 721.23 | 713.44 | Upgrade
|
| Additional Paid-In Capital | 262.65 | 262.65 | 255.64 | 255.63 | 255.54 | 193.81 | Upgrade
|
| Retained Earnings | -180.94 | -162.32 | -31.56 | 119.94 | 387.95 | 464.73 | Upgrade
|
| Treasury Stock | -110.02 | -110.02 | -108.37 | -56.26 | - | - | Upgrade
|
| Comprehensive Income & Other | 58.21 | 58.21 | 94.09 | 94.09 | 94.11 | 107.89 | Upgrade
|
| Shareholders' Equity | 751.14 | 769.76 | 931.04 | 1,135 | 1,459 | 1,480 | Upgrade
|
| Total Liabilities & Equity | 1,231 | 1,255 | 1,625 | 1,855 | 2,514 | 2,716 | Upgrade
|
| Total Debt | 267.07 | 264.26 | 565.61 | 619.97 | 949.22 | 887.29 | Upgrade
|
| Net Cash (Debt) | 3.56 | 21.05 | 168.4 | 345.3 | 616.84 | 859.69 | Upgrade
|
| Net Cash Growth | -97.19% | -87.50% | -51.23% | -44.02% | -28.25% | 39.40% | Upgrade
|
| Net Cash Per Share | 0.01 | 0.03 | 0.23 | 0.48 | 0.86 | 1.13 | Upgrade
|
| Filing Date Shares Outstanding | 703.54 | 703.54 | 703.83 | 721.24 | 721.23 | 713.44 | Upgrade
|
| Total Common Shares Outstanding | 703.54 | 703.54 | 703.83 | 721.24 | 721.23 | 713.44 | Upgrade
|
| Working Capital | 365.45 | 367.3 | 638.42 | 829.62 | 1,139 | 1,307 | Upgrade
|
| Book Value Per Share | 1.07 | 1.09 | 1.32 | 1.57 | 2.02 | 2.07 | Upgrade
|
| Tangible Book Value | 651.96 | 668.86 | 822.61 | 1,019 | 1,333 | 1,375 | Upgrade
|
| Tangible Book Value Per Share | 0.93 | 0.95 | 1.17 | 1.41 | 1.85 | 1.93 | Upgrade
|
| Buildings | - | 374.09 | 378.47 | 369.78 | 316.92 | 320.8 | Upgrade
|
| Machinery | - | 162.03 | 187.09 | 191.33 | 197.49 | 189.79 | Upgrade
|
| Construction In Progress | - | 228.22 | 220.06 | 190.18 | 187.96 | 159.3 | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.